Monday, June 15, 2026

Celltrion Launches New Autoimmune Drug Avtozma in Japan

Celltrion launches Avtozma for autoimmune diseases in Japan, expanding its product portfolio and strengthening market presence.

Viral AI Image Pushes ChatGPT to 2.5M DAUs, 500M Users Globally

ChatGPT's daily active users in South Korea surged to 2.55 million, driven by Ghibli-style image generation, as OpenAI expands its paid services.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

Tag: New Zealand

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Celltrion’s Ramucirumab and Infliximab: The Secrets Behind Their Dominance in Oceania’s Biopharmaceutical Market

Celltrion's cancer and autoimmune products are expanding market share in Australia and New Zealand, enhancing influence in Oceania.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.